← Back to headlines
Amgen and AstraZeneca Launch Real-Time Drug Trials as FDA Expedites Development with AI
Pharmaceutical companies Amgen and AstraZeneca have begun real-time drug trials, coinciding with the FDA's use of artificial intelligence to speed up drug development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
Technion Establishes New Aerospace Prize to Honor Industry Leaders
just now
Philippines Education Secretary Advocates for AI in Education
just now
Claire Danes to star in Netflix remake of Israeli series Lovesick
just now